For centuries, we have studied cancer and the affects it bestows upon the human body. Today, we try a variety of methods to tackle cancer and beat it. For our project, we decided to focus our attention on lung cancer. In specifically, non-small cell lung cancer. According to the American Cancer Society about 80%-85% suffer from non-small cell lung cancer. Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are subtypes of non-small cell lung cancer (NSCLC). We will be focusing on KRAS and its association with lung adenocarcinoma. In addition, we will also be discussing Keap1 and AATF. One challenge will be facing during our research, is in delivering a treatment that would only target the cancer cells. One idea we are looking into at this moment is to create a drug that will be delivered intravenous. We will be targeting the lungs via the pulmonary vein. Non-small cell lung cancer is a type of cancer which we will be able to build off since it is also known to be metastatic.
Comments
Menyioning Squamous cell and
Menyioning Squamous cell and large cell carcinoma subtypes could be left out as it can be considered "fillers" as you have stated after that you will be focusing on adenocarcinoma.
Using first person in a paper
Using first person in a paper like this is often not the best idea. Try making it more objective by using third person.
You should also identify what
You should also identify what these different abbreviations mean like AATF and KRAS. The intro is a good time to explain to the reader what these things are.